why choose us

Clinical Trials Search

Showing 11,750 of 132,366 result(s)
Fluvoxamine for Long COVID-19

Status: Completed

Condition: Long COVID

Interventions: Fluvoxamine is an FDA approved drug for the treatment of OCD.
This trial is testing the effects of the drug on long COVID.

Date: 2023-05-22

Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension

Status: Completed

Condition: Postpartum Hypertension

Interventions: Remote home blood pressure (BP) monitoring once a day for the first 7 days and then at least weekly or more frequently as per a standardized blood pre

Date: 2023-05-22

Improving Prosthetic Provision in Rural Communities: Limb Scanning With Caregiver Assistance

Status: Completed

Condition: Lower Extremity Amputation

Interventions: A prosthetic socket whose shape was captured by a study helper using digital methods (i.e., 3D scanner).
The digital file describing the socket d

Date: 2023-05-22

Treatment for Improvement of Cellulite Appearance Using Form Applicator

Status: COMPLETED

Condition: Cellulite

Interventions:

The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percut

Date: 2023-05-22

ACT for Healthy Living: a Brief Acceptance and Commitment Therapy Intervention for Women With Obesity

Status: Completed

Condition: Obesity

Interventions: This workshop is a brief behavioral intervention that teaches acceptance and commitment therapy skills (e.g., values clarification, acceptance, commit

Date: 2023-05-22

Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria

Status: NOT_YET_RECRUITING

Condition: Urothelial Carcinoma

Interventions: Cxbladder tests uses mRNA and DNA biomarkers in the urine to direct the management of UC from diagnosis to surveillance for disease recurrence.

Date: 2023-05-22

Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP

Status: NOT_YET_RECRUITING

Condition: Erythropoietic Protoporphyria

Interventions: DISC-1459 dose level 1

Date: 2023-05-22

Nasal Obstruction and Olfactory Losses

Status: Completed

Condition: Nasal Obstruction

Interventions: Please see the arm description for details.

Date: 2023-05-22

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Status: Completed

Condition: PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Interventions: RP-A601 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74)
capsid encapsulating the transgene, human plakophilin 2 (PKP2)

Date: 2023-05-22